Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: an early access programme for spanish patients with genotype 1/4 chronic hepatitis c virus infection

Authors: Perelló, C., Carrión, J. A., Ruiz‐Antorán, B., Crespo, J., Turnes, J., Llaneras, J., Lens, S., Delgado, M., García‐Samaniego, J., García‐Paredes, F.

Source: JOURNAL OF VIRAL HEPATITIS. 24(3):226-237

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN389484554&indx=1&recIds=ETOCRN389484554

Bronchopulmonary Penetration of Isavuconazole in Lung Transplant Recipients

Authors: Darnaude-Ximénez, I., Caballero-Bermejo, A., Aguilar-Perez, M., Gómez-López, A., Sancho-López, A., García-Gallo, C. López, Nuevo, G. Díaz, Diago-Sempere, E., Ruiz-Antorán, B., Ussetti-Gil, P.

Source: Journal of heart and lung transplantation. 42(S):S99-S99

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100191408983.0x000001&indx=1&recIds=ETOCvdc_100191408983.0x000001

Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol

Authors: Ruiz-Antorán, B., Agustí Escasany, A. n., Vallano Ferraz, A., Danés Carreras, I., Riba, N., Mateu Escudero, S., Costa, J., Sánchez Santiago, M. B., Laredo, L., Durán Quintana, J. A.

Source: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 66(6):633-641

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN270953849&indx=1&recIds=ETOCRN270953849

(200) Bronchopulmonary Penetration of Isavuconazole in Lung Transplant Recipients

Authors: Darnaude-Ximénez, I., Caballero-Bermejo, A., Aguilar-Perez, M., Gómez-López, A., Sancho-López, A., García-Gallo, C. López, Nuevo, G. Díaz, Diago-Sempere, E., Ruiz-Antorán, B., Ussetti-Gil, P.

Source: In Journal of Heart and Lung Transplantation April 2023 42(4) Supplement:S99-S99

Adherence to SmPC recommendations in real-world practice in the treatment of monoinfected patients with chronic genotype 1 or 4 HCV infection with direct-acting antivirals

Authors: Ruiz-Antorán, B., Rincón, D., Perelló, C., Fernandez, I., Gea, F., Mariño, Z., García-Samaniego, J., Hontangas, V., Cabezas, J., Sacristan, B., Pascasio, J.M., Morillas, R.M., Turnes, J., Llaneras, J., Serra, M.A., Torras, X., Diago, M., Jorquera, F., Fernández, C., Simón, M.A., Bermejo, M.F., Ruano, J.J.S., Arenas, J., Andrade, R.J., Ampuero, J., Bonet, L., Crespo, J., Panero, J.L.C.

Source: Journal of hepatology. 66(1):S522-S523

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100050869262.0x000001&indx=1&recIds=ETOCvdc_100050869262.0x000001

Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice

Authors: Ruiz-Antorán, B., Rincón, D., Conde, M.H., Fernández, I., García-Samaniego, J., Gea, F., Cabezas, J., Sacristán, B., Jorquera, F., Turnes, J., Prieto, M., Llaneras, J., Pascasio, J.M., Royuela, F.S., Lens, S., Serra, M.A., Morillas, R.M., Torras, X., Andrade, R.J., Bermejo, M.F., Ampuero, J., Molina, E., Bonet, L., Diago, M., Salcines, J.R., Moreno, J.M., Crespo, J., Panero, J.L.C.

Source: Journal of hepatology. 66(1):S523-S524

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100050869261.0x000001&indx=1&recIds=ETOCvdc_100050869261.0x000001

This result is not displayed to guests.
Login for full access.

FRI-254 - Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice

Authors: Ruiz-Antorán, B., Rincón, D., Conde, M.H., Fernández, I., García-Samaniego, J., Gea, F., Cabezas, J., Sacristán, B., Jorquera, F., Turnes, J., Prieto, M., Llaneras, J., Pascasio, J.M., Royuela, F.S., Lens, S., Serra, M.A., Morillas, R.M., Torras, X., Andrade, R.J., Bermejo, M.F., Ampuero, J., Molina, E., Bonet, L., Diago, M., Salcines, J.R., Moreno, J.M., Crespo, J., Panero, J.L.C.

Source: In Journal of Hepatology 2017 66(1) Supplement:S523-S524

FRI-253 - Adherence to SmPC recommendations in real-world practice in the treatment of monoinfected patients with chronic genotype 1 or 4 HCV infection with direct-acting antivirals

Authors: Ruiz-Antorán, B., Rincón, D., Perelló, C., Fernandez, I., Gea, F., Mariño, Z., García-Samaniego, J., Hontangas, V., Cabezas, J., Sacristan, B., Pascasio, J.M., Morillas, R.M., Turnes, J., Llaneras, J., Serra, M.A., Torras, X., Diago, M., Jorquera, F., Fernández, C., Simón, M.A., Bermejo, M.F., Ruano, J.J.S., Arenas, J., Andrade, R.J., Ampuero, J., Bonet, L., Crespo, J., Panero, J.L.C.

Source: In Journal of Hepatology 2017 66(1) Supplement:S522-S523

Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under 'Real-Life' Conditions

Authors: Ruiz-Antorán, B., Pascasio, J. M., Gea, F., Barcena, R., Larrubia, J., Pérez, l. R., Sousa, J., Romero, G. m., Solá, R., de, l. R.

Source: VALUE IN HEALTH. 17(7):A367-A367

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN362025412&indx=1&recIds=ETOCRN362025412

LBP512 - Effectiveness and Safety of Ombitasvir, Paritaprevir, Ritonavir and Dasabuvir Patients with Genotype 1 Chronic Hepatitis C Virus Infection: Results from the Spanish Real World Cohort

Authors: Calleja, J.L., Rincon, D., Ruiz-Antoran, B., Sacristan, B., Perello, C., Lens, S., Fernanadez, I., Gea, F., Morillas, R.M., Cabezas, J., Pascasio, J.M., Prieto, M., Turnes, J., Serra, M.A., Arenas, J., Torras, X., Bonet, L., Fernandez, C., Samaniego, J., Hernandez-Albujar, A., Ampuero, J., Moreno, J.M., Saez-Royuela, F., Alvarez-Navascues, C., Diago, M., Sanchez-Antolin, G., de la Vega, J., Sanchez-Ruano, J.J., Andrade, R., Butti, M., Carrion, J.A., Molina, E., Simon, M.A., Salcines, J.R., Jorquera, F., Montoliu, S., Ahumada, A., Hernaez, T., Crespo, J.

Source: In Journal of Hepatology 2016 64(2) Supplement:S218-S219

Randomized Clinical Trial, Placebo Compared To Evaluate The Efficacy And Safety of Minocycline In Angelman Syndrome (A-Manece Study)

Authors: Ruiz-Antorán, B., Sancho López, A., Cazorla, R., Iglesias, G., Lara, J., López Pájaro, L., Marín, E., Avendaño-Solá, C.

Source: In Clinical Therapeutics August 2015 37(8) Supplement:e154-e155

Cost-Effectiveness Analysis of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions

Authors: Ruiz-Antorán, B., Pascasio, J.M., de la Revilla, J., Crespo, J., Salcedo de Diego, I., Payares, C., Forns, X., Calleja, J.L., Avendaño-Solá, C.

Source: In Clinical Therapeutics August 2015 37(8) Supplement:e154-e154

Impact of A Multicomponent Intervention On Registered Nurses To Increase Reporting Of Adverse Drug Reactions And Medication Errors

Authors: Salcedo de Diego, I., Serrano Gallardo, P., Ruiz Antorán, B., de Andrés Gimeno, B., Revuelta Zamorano, M., Avendaño Solá, C.

Source: In Clinical Therapeutics August 2015 37(8) Supplement:e153-e153

Sentia: A Spanish Systematic Online Monitoring Registry for Children And Adolescents Treated With Antipsychotics: Results from A 2-Year, Naturalistic Follow-Up Study

Authors: Centeno Soto, G., Ruiz-Antorán, B., Palanca Maresca, I., Forti-Buratti, A., Avendaño-Solá, C.

Source: In Clinical Therapeutics August 2015 37(8) Supplement:e153-e153

Conversion from Tacrolimus Twice-Daily to Tacrolimus Once-Daily In Stable Cystic Fibrosis Lung Transplant Recipients: Comparative Pharmacokinetics

Authors: Centeno Soto, G., Ruiz-Antorán, B., Sancho López, A., Payares, C., Fernández, F.J., Ussetti, P., Avendaño-Solá, C.

Source: In Clinical Therapeutics August 2015 37(8) Supplement:e152-e153

This result is not displayed to guests.
Login for full access.

PGI25 - Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions

Authors: Ruiz-Antorán, B., Pascasio, J.M., Gea, F., Barcena, R., Larrubia, J., Pérez, Álvarez R., Sousa, J., Romero, Gómez M., Solá, R., de, la Revilla. J., Crespo, J., Navarro, J., Arenas, J., Delgado, M., Fernández, Rodríguez C., Planas, R, Buti, M., Forns, X., Calleja, J.L.

Source: In Value in Health November 2014 17(7):A367-A367

P1183 VIRAL BREAKTHROUGH DURING TRIPLE THERAPY: CAUSES OF NON RESPONSE IN A MULTICENTRIC COHORT

Authors: Calleja Panero, J.L., Crespo, J., Rodríguez, R., Serra, M.A., Pascasio, J.M., Sola, R., Morillas, R., Romero, M., Lens, S., García Samaniego, J., Ruiz Antorán, B., Turnes, J.

Source: In Journal of Hepatology April 2014 60(1) Supplement:S480-S480

P1158 EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAM

Authors: Bruno, S., Bollani, S., Pascasio, J.M., Zignego, A.L., Di Marco, V., Magni, C., Rizzetto, M., Ciancio, A., Alberti, A., Piovesan, S., Mangia, A., De la Revilla, J., Larrubia, J.R., Gea, F., Babudieri, S., Perez-Alvarez, R., Colletta, C., Barcena, R., Forns, X., Romero-Gomez, M., Koch, M., Massari, M., Caremani, M., Crespo, J., Navarro, J.M., Arenas, J., Delgado, M.B., Pirisi, M., Zuin, M., Licata, A., Mazzotta, F., Colombo, A., Russello, M., Fermandez, I., Santantonio, T., Fernandez-Rodriguez, C.M., Farina, F., Ruiz Antoran, B., Maisonneuve, P., Craxì, A., Calleja, J.L.

Source: In Journal of Hepatology April 2014 60(1) Supplement:S470-S470